Dupilumab, a fully human monoclonal antibody, inhibits the signaling of the interleukin 4 (IL-4) and IL-13 pathways.
Costs of at least 350 branded medications, including vaccines against Covid-19, shingles and cancer treatment Ibrance, will ...
Pfizer (NYSE:PFE) and GlaxoSmithKline (NYSE:GSK) are among the top drugmakers planning price increases for hundreds of ...
GSK plc (NYSE:GSK) is one of the best affordable healthcare stocks to buy now. GSK plc (NYSE:GSK) announced on December 19 an ...
The White House announced Friday that nine additional pharmaceutical companies have agreed to follow President Trump’s “most ...
According to him, this has been a year where certain areas of healthcare, particularly those related to health spend or real ...
An announcement from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK plc has continued its share buyback programme, repurchasing 232,912 ...
A study suggests twice-yearly Yeztugo offers HIV prevention without adversely affecting gender-affirming care.
Health and Me on MSN
Despite Trump warnings, drugmakers raise prices on 350 medicines in the US
US drugmakers plan to raise prices on 350 prescription medicines, including Covid-19 vaccines and cancer treatments, despite ...
Although development of a jab for the H5N1 strain of avian flu is well under way, other strains are receiving less attention ...
TD Cowen analyst Steve Scala maintained a Hold rating on GlaxoSmithKline today and set a price target of $52.00. According to TipRanks, Scala is a 4-star analyst with an average return of 10.7% and a ...
A roundup of Mad in America's most read blogs and personal stories of 2025 as chosen by our readers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results